SV2A missense mutation facilitates the kindling epileptogenesis

被引：0

作者：

Ohno, Yukihiro ^{[1
]}

Mashimo, Tomoji ^{[2
]}

Okumura, Takahiro ^{[1
]}

Ishihara, Shizuka ^{[1
]}

Terada, Ryo ^{[1
]}

Shimizu, Saki ^{[1
]}

Tokudome, Kentaro ^{[1
]}

Chie, Tomita ^{[1
]}

Kitaya, Ryosuke ^{[1
]}

Tanaka, Tomoya ^{[1
]}

Kunisawa, Naofumi ^{[1
]}

Sasa, Masashi ^{[3
]}

Serikawa, Tadao ^{[2
]}

机构：

[1] Osaka Univ Pharm Sci, Pharmacol Lab, Takatsuki, Osaka 5691094, Japan

[2] Kyoto Univ, Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan

[3] Nagisa Clin, Hirakata, Osaka 5731183, Japan

来源：

JOURNAL OF PHARMACOLOGICAL SCIENCES | 2013年 / 121卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：87P / 87P

页数：1

共 50 条

[41] Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes
Hayashi, M
Yatsushiro, S
Yamada, H
Yamamoto, A
Futai, M
Yamaguchi, A
Moriyama, Y
MELATONIN AFTER FOUR DECADES: AN ASSESSMENT OF ITS POTENTIAL, 1999, 460 : 91 - 93
[42] Regulation of kindling epileptogenesis by hippocampal Toll-like receptors 2
Medel-Matus, Jesus-Servando
Reynolds, Ashley
Shin, Don
Sankar, Raman
Mazarati, Andrey
EPILEPSIA, 2017, 58 (08) : E122 - E126
[43] Imaging the effect of ketamine on synaptic density (SV2A) in the living brain
Holmes, Sophie E.
Finnema, Sjoerd J.
Naganawa, Mika
DellaGioia, Nicole
Holden, Daniel
Fowles, Krista
Davis, Margaret
Ropchan, Jim
Emory, Paul
Ye, Yunpeng
Nabulsi, Nabeel
Matuskey, David
Angarita, Gustavo A.
Pietrzak, Robert H.
Duman, Ronald S.
Sanacora, Gerard
Krystal, John H.
Carson, Richard E.
Esterlis, Irina
MOLECULAR PSYCHIATRY, 2022, 27 (04) : 2273 - 2281
[44] Structural basis for antiepileptic drugs and botulinum neurotoxin recognition of SV2A
Yamagata, Atsushi
Ito, Kaori
Suzuki, Takehiro
Dohmae, Naoshi
Terada, Tohru
Shirouzu, Mikako
NATURE COMMUNICATIONS, 2024, 15 (01)
[45] Genetic variation at the synaptic vesicle gene SV2A is associated with schizophrenia
Mattheisen, Manuel
Muehleisen, Thomas W.
Strohmaier, Jana
Treutlein, Jens
Nenadic, Igor
Alblas, Margrieta
Meier, Sandra
Degenhardt, Franziska
Herms, Stefan
Hoffmann, Per
Witt, Stephanie H.
Giegling, Ina
Sauer, Heinrich
Schulze, Thomas G.
Rujescu, Dan
Noethen, Markus M.
Rietschel, Marcella
Cichon, Sven
SCHIZOPHRENIA RESEARCH, 2012, 141 (2-3) : 262 - 265
[46] Synaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes
Hayashi, T
Yamamoto, A
Yatsushiro, S
Yamada, H
Futai, M
Yamaguchi, A
Moriyama, Y
JOURNAL OF NEUROCHEMISTRY, 1998, 71 (01) : 356 - 365
[47] Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
Crowder, KM
Gunther, JM
Jones, TA
Hale, BD
Zhang, HZ
Peterson, MR
Scheller, RH
Chavkin, C
Bajjalieh, SM
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) : 15268 - 15273
[48] SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment
Lezzi, M
Theander, S
Janz, R
Loze, C
Wollheim, CB
JOURNAL OF CELL SCIENCE, 2005, 118 (23) : 5647 - 5660
[49] Measuring Synaptic Density in Parkinson's Disease With SV2A PET imaging
Matuskey, David
Dias, Mark
Naganawa, Mika
Toyonaga, Takuya
Henry, Shannan
Ropchan, Jim
Nabulsi, Nabeel
Huang, Yiyun
Suridjan, Ivonne
Comley, Robert
Finnema, Sjoerd J.
Tinaz, Sule
Carson, Richard E.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2019, 31 (03) : E19 - E19
[50] The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, BA
Lambeng, N
Nocka, K
Kensel-Hammes, P
Bajjalieh, SM
Matagne, A
Fuks, B
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) : 9861 - 9866

← 1 2 3 4 5 →